Moffitt to install TomoTherapy® Hi•Art Systems for radiation therapy

May 10, 2006

Tampa, FL - H. Lee Moffitt Cancer Center & Research Institute will be installing three TomoTherapy® Hi•Art Systems for radiation therapy. Doctors plan to begin treating patients as soon as August.

Incorporating features that facilitate treatment planning, dose targeting, precise IG/IMRT treatment delivery, and effective adaptive planning, the TomoTherapy Hi•Art System offers Moffitt unprecedented day-to-day flexibility and productivity, which adds up to improved care for patients.

“TomoTherapy’s imaging capability allows us to follow patient response to treatment on a daily basis,” says Dr. Craig Stevens, Moffitt’s Division Chief, Radiation Oncology. “For instance, if a tumor responds quickly, this could cause an increase in radiation dose to healthy tissue. We will now be able to detect the response and adapt our therapy accordingly, allowing us to further individualize our treatment approach to every patient.”

The TomoTherapy Hi•Art System is now being used to treat patients in North America, Greater Europe and Asia Pacific.

“Moffitt is consistently rated among the leading cancer hospitals in the United States,” says Dr. Fred Robertson, CEO of TomoTherapy, Inc. “We’re excited about the possibilities of this partnership. It’s one more significant step in the reshaping of radiation therapy.”

About H. Lee Moffitt Cancer Center & Research Institute

In 2001, H. Lee Moffitt Cancer Center & Research Institute earned NCI Comprehensive Cancer Center status in recognition of its excellence in research and contributions to clinical trials, prevention and cancer control. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers, and is listed in U.S. News & World Report as one of America’s Best Hospitals for cancer. Moffitt’s sole mission is to contribute to the prevention and cure of cancer.

About TomoTherapy Incorporated

Based in Madison, Wisconsin, TomoTherapy Incorporated has developed a revolutionary new medical system that combines on-board CT imaging with conformal radiation therapy to provide unprecedented precision in the treatment of cancer patients. The TomoTherapy Hi•Art System is designed to target radiation treatment to the patient’s tumor while helping to limit damage to the surrounding tissues. The TomoTherapy technology was created from collaboration with the University of Wisconsin.